A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Randomized, double-blind, placebo-controlled study with two treatment arms (Tamsulosin OCAS 0.4 mg \& placebo). The study comprises a 2-week placebo run-in followed by a 12-week treatment period.
Epistemonikos ID: bb1b9781bf7a7b59812d18be30b151f3f391526f
First added on: May 04, 2024